2026 NPPES data Interventional Pain Medicine Physician NPI 1013303320 MD
Verify on CMS →

THOMAS CESTARE, MD

Interventional Pain Medicine Physician in BRANDYWINE, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
255
Medicare Part D claims · 76 beneficiaries · Interventional Pain Medicine Physician avg: 2K
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
45/100
▼ 38 pts below national avg 83.1 · [object Object]
What the federal data reveals: THOMAS CESTARE, MD is a Interventional Pain Medicine Physician ([object Object]) practicing in BRANDYWINE, Maryland with a Medicare Part D prescribing footprint of 255 claims across 76 beneficiaries — 8% brand-name prescribing . Their CMS MIPS Final Score of 45/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: THOMAS CESTARE, MD reported a CMS MIPS final score of 45 out of 100, below the 83.1 national average, and filed 255 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

THOMAS CESTARE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

THOMAS CESTARE, MD at a glance

Below national average

NPI registry status

Active

Issued 04/13/2015

NPI 1013303320

Primary specialty

Interventional Pain Medicine Physician

Niche

1,528 US NPIs in this specialty

Medicare Part D claims

255 88% vs specialty avg

2023 prescription claims

Specialty avg: 2,197

MIPS final score

45/100 38.099999999999994% pts

Below average band

vs 83.1 national avg

Specialty distribution in Maryland

How Interventional Pain Medicine Physician compares to other specialties among Maryland providers

Maryland providers

Interventional Pain Medicine Physician share within Maryland

1. Interventional Pain Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Interventional Pain Medicine Physician share within Maryland

Medicare quality performance — MIPS

THOMAS CESTARE, MD's 2023 MIPS final score plotted against the Interventional Pain Medicine Physician national average

Below national average
MIPS Final Score
45/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Interventional Pain Medicine Physician) — 45/100 vs national avg 83.1

0%100%National avg83%45%
MIPS final score (Interventional Pain Medicine Physician) — 45/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

THOMAS CESTARE, MD is a Interventional Pain Medicine Physician provider practicing in BRANDYWINE, Maryland, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1013303320. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

THOMAS CESTARE, MD appears in the CMS NPPES registry as a Interventional Pain Medicine Physician provider holding MD credentials at 13950 BRANDYWINE RD, BRANDYWINE, MD, 20613, with a listed phone of (301) 782-2220. NPI 1013303320 was issued on 04/13/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CESTARE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 255 prescription claims written by this provider, covering 76 Medicare beneficiaries and totaling roughly $19K in drug spend, split 8% brand-name and 92% generic by claim count, with an opioid prescribing rate of 21.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 45/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Interventional Pain Medicine Physician is a narrow specialty nationwide, with 1,528 enrolled providers across 53 states and an average of 2,197 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

13950 BRANDYWINE RD
BRANDYWINE, MD 20613

Provider Details

NPI 1013303320
Specialty Interventional Pain Medicine Physician
Credentials MD
Gender Male
NPI Issued 04/13/2015

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

45
Final Score
Avg: 83.1
0
Quality
100
Promoting Interoperability

Reporting: Individual

Hospital and facility affiliations

Facilities where THOMAS CESTARE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MEDSTAR MEDICAL GROUP II LLC
LEONARDTOWN, MD
SUBURBAN/NRH MEDICAL REHABILITATION INC
BETHESDA, MD

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Generic-heavy

THOMAS CESTARE, MD — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 255 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

255
Total Claims
$19K
Total Drug Cost
76
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
326
Total Day Supply
9,324
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$14K
Generic Drug Cost
$5K
Opioid Claims
54 (21.2% rate)

Patient Demographics

Average Patient Age
70.2 years
Avg HCC Risk Score
1.29
Gender Split
76% female / 24% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Gabapentin
86
Pregabalin
42
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
22
Baclofen
18
Nucynta
Tapentadol Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Interventional Pain Medicine Physician Overview

How THOMAS CESTARE, MD fits within the Interventional Pain Medicine Physician landscape nationally.

1,528
Interventional Pain Medicine Physician Providers in US
53
States with Interventional Pain Medicine Physician
2,197
Avg Claims per Provider

THOMAS CESTARE, MD's 255 claims are below the specialty average of 2,197.

Nearby Interventional Pain Medicine Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as CESTARE.

Compare Interventional Pain Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is THOMAS CESTARE, MD's specialty?
THOMAS CESTARE, MD specializes in Interventional Pain Medicine Physician and practices in BRANDYWINE, Maryland. Credentials: MD.
How much does THOMAS CESTARE, MD prescribe under Medicare Part D?
In 2023, THOMAS CESTARE, MD wrote 255 Medicare Part D claims totaling $19K in drug costs for 76 beneficiaries.
What is THOMAS CESTARE, MD's Medicare quality score?
THOMAS CESTARE, MD has a CMS MIPS Final Score of 45/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is THOMAS CESTARE, MD located?
THOMAS CESTARE, MD is located at 13950 BRANDYWINE RD, BRANDYWINE, MD, 20613. Phone: (301) 782-2220.
What is THOMAS CESTARE, MD's NPI number?
THOMAS CESTARE, MD's National Provider Identifier (NPI) is 1013303320, issued on 04/13/2015.
Does THOMAS CESTARE, MD prescribe more brand-name or generic drugs?
THOMAS CESTARE, MD's prescribing is 8% brand-name and 92% generic drugs by claim count, with $14K in brand drug costs.
Does THOMAS CESTARE, MD prescribe opioids?
Yes, THOMAS CESTARE, MD had 54 opioid claims in 2023 with an opioid prescribing rate of 21.2%.
How many Interventional Pain Medicine Physician providers are there in the US?
There are 1,528 Interventional Pain Medicine Physician providers across 53 states in the US. The average Interventional Pain Medicine Physician provider writes 2,197 Medicare Part D claims per year.
What drugs does THOMAS CESTARE, MD prescribe most often?
Based on 2023 Medicare Part D data, THOMAS CESTARE, MD's most frequently prescribed drugs include Gabapentin, Pregabalin, Oxycodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does THOMAS CESTARE, MD accept Medicare?
THOMAS CESTARE, MD appears in CMS Medicare data with 255 Part D claims and 76 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify THOMAS CESTARE, MD's credentials?
THOMAS CESTARE, MD's NPI is 1013303320 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology